Modelling the value of risk-stratified skin cancer screening of asymptomatic patients by dermatologists.

Hartman, R I; Xue, Y; Singer, S; Markossian, T W; Joyce, C; Mostaghimi, A

Hartman, R I; Xue, Y; Singer, S; Markossian, T W; Joyce, C; Mostaghimi, A.

Afiliação

Hartman RI; Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Xue Y; Harvard Combined Dermatology Residency Training Program, Boston, MA, USA.
Singer S; Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Markossian TW; Department of Public Health Sciences, Loyola University Stritch School of Medicine, Chicago, IL, USA.
Joyce C; Department of Public Health Sciences, Loyola University Stritch School of Medicine, Chicago, IL, USA.
Mostaghimi A; Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Br J Dermatol ; 183(3): 509-515, 2020 09.

Article em En | MEDLINE | ID: mdl-31867714

Assuntos

Melanoma; Neoplasias Cutâneas; Adulto; Dermatologistas; Detecção Precoce de Câncer; Humanos; Melanoma/diagnóstico; Melanoma/epidemiologia; Estudos Prospectivos; Neoplasias Cutâneas/diagnóstico; Neoplasias Cutâneas/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google